Monitoring Living Donor Liver Functions by Thromboelastometry
NCT ID: NCT02336191
Last Updated: 2017-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2014-06-30
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney
NCT02059460
Left Lobe Versus Right Lobe in Adult Living Donor Liver Transplantation in Borderline GRWR
NCT06542913
A Study of Retrograde rEperfusion in Dbd Donor LIver Transplantation
NCT02423941
Molecular Assessment and Profiling of Liver Transplant Recipients
NCT04793360
Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation
NCT05448339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study period: from June 2014 to May 2015 The early post-operative graft functions will be correlated with concomitant monitored thromboelastometric (TEM) parameters derived from a ROTEM Delt device
TEM Samples will be collected at the following times:
Pre-transplant 10 minutes post portal declamping at ICU admission Morning of Days from 1 to 7 Laboratory data relevant to graft functional status will be collected at the same times.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LDLT Recipients
Patients subjected to living donor liver transplantation
living donor liver transplantation
living donor liver transplantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
living donor liver transplantation
living donor liver transplantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amr M. Yassen
Professor of Anesthesia and Intensive Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
amr M Yassen, MD
Role: PRINCIPAL_INVESTIGATOR
MAnsoura Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gastroenerology Surgical Center - Liver transplantation program
Al Mansurah, Dakahlia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MansouraU_LDLT_TEG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.